Related Experiment Video
Updated: May 24, 2026

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
Published on: July 27, 2022
Enhanced Bioavailability and Dissolution of Atorvastatin Calcium from Floating Microcapsules using Minimum Additives
Furquan Nazimuddin Khan1, Mohamed Hassan G Dehghan
1Y. B. Chavan College of Pharmacy, Department of Pharmaceutics, Dr. Rafiq Zakaria Campus, Rauza Bagh, Aurangabad-431001, India.
Floating microcapsules improved atorvastatin calcium (ATC) bioavailability by enhancing gastric residence time. The developed microcapsules significantly increased drug dissolution and absorption compared to conventional formulations.
Area of Science:
- Pharmaceutical Technology
- Drug Delivery Systems
- Biopharmaceutics
Background:
- Atorvastatin calcium (ATC) exhibits poor bioavailability due to low solubility in acidic environments.
- Optimal absorption of ATC occurs in the upper gastrointestinal (GI) tract.
- Extended gastric residence time is crucial for enhancing ATC bioavailability.
Purpose of the Study:
- To develop multiple-unit floating microcapsules of atorvastatin calcium (ATC).
- To improve the gastric residence time and bioavailability of ATC.
- To enhance the dissolution rate of ATC using dioctyl sodium sulphosuccinate (DSS).
Main Methods:
- Floating microcapsules were prepared using the emulsion-solvent evaporation technique.
- Dioctyl sodium sulphosuccinate (DSS) was incorporated as a dissolution enhancer.
- Characterization included SEM, DSC, PXRD, particle size, drug entrapment, stability, and in-vitro dissolution studies.
Main Results:
- Spherical ATC-loaded floating microcapsules with high drug loading (96.55%) and optimal particle size (~28.10 μm) were successfully prepared.
- Microcapsules formulated with DSS demonstrated significantly higher in-vitro drug dissolution rates.
- The optimized formulation (AT4) achieved 97.86% drug dissolution, markedly exceeding the reference product (54%) over 12 hours.
- Pharmacokinetic studies in rabbits showed a 1.7-fold increase in ATC bioavailability with AT4 microcapsules.
Conclusions:
- Multi-unit floating microcapsules are an effective strategy for improving the bioavailability of atorvastatin calcium.
- The incorporation of DSS as a dissolution enhancer significantly boosts ATC release from floating microcapsules.
- This novel drug delivery system holds promise for enhancing the therapeutic efficacy of atorvastatin calcium.
Related Concept Videos
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Bioavailability Enhancement: Drug Permeability Enhancement
Bioavailability Enhancement: Drug Solubility Enhancement
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Factors Affecting Dissolution: Particle Size and Effective Surface Area
Factors Influencing Drug Absorption: Pharmaceutical Parameters
